Advicenne

Advicenne

Develops and markets pediatric drugs for the treatment of neurological diseases of the central nervous system and nephrological disorders. Learn more

Launch date
Employees
Market cap
€13.4m
Enterprise valuation
€36m (Public information from Sep 2024)
Company register number 497587089
Paris Île-de-France (HQ)
Authorizing premium user...